Summary Survival rates for 67 women with bilateral breast cancer were compared to those for 1282 women with unilateral disease in a follow-up of 1349 women participating in a population-based study. Relative survival at 8 years of follow-up was 69% for women with unilateral disease as compared to 53% for women with bilateral cancer. When possible confounding histopathological differences -data about which were prospectively collected -and age were adjusted for in a multivariate analysis, the relative hazard rate was significantly higher for women with bilateral versus unilateral breast cancer (P=0.006). The al., 1984;Turco et al., 1982). However, the findings in several studies of these survival rates are afflicted with uncertainty on account of selection of the patient material, lack of control of confounding factors and inadequate statistical methods.We addressed these questions specifically in a long-term follow-up of women participating in a population-based case-control study which included nearly all incident cases of breast cancer from one third of the Swedish population diagnosed during a 14-month period (Adami et al., 1985). The observed and relative survival were compared between women with bilateral and those with unilateral breast cancer. The influence of the time interval between diagnosis of the two cancers was also analyzed. Confounding factors were taken into account by multivariate techniques.
Materials and methods
PatientsAll incident cases of breast cancer were registered continuously during a 14-month period in 1977-78 for the purpose of a case-control study (Adami et al., 1985). The study was population-based and covered nearly one-third of the total Swedish population.During the study period 1,423 incident cases were registered. Within two months after diagnosis a questionnaire was mailed to all patients in order to obtain information on epidemiologic characteristics. Twenty-three women had died, 37 did not respond to the questionnaire and 14 gave incomplete answers.
TreatmentThe women were treated in several different hospitals in 11 counties and the treatment was accordingly not uniform. However, total mastectomy was the only accepted routine method for operable cases during this period of time. Owing to regional differences in the treatment protocol, biopsy or clearance of the axilla was not always performed, and a total of 38 women were considered to be inoperable. The distribution of these two treatment variants did not differ between unilateral and bilateral cancers: roughly 63% of the women had an axillary clearance and 97% were deemed operable in both groups. Routinely, postoperative irradiation was given to women with stage II disease and/or when the resection margins were invaded by tumour growth. During the period of patient accrual, adjuvant systemic treatment was used only at one hospital and exclusively for node-positive patients.Histopathologic evaluation All available slides were re-examined blindly by one and the same pathologist. The histologic classification accordin...